Skip to main content

Table 3 CMR-Based Change in Diagnosis

From: Clinical utility of cardiovascular magnetic resonance imaging in patients with implantable cardioverter defibrillators presenting with electrical instability or worsening heart failure symptoms

Post-CMR diagnosis

All patients (n = 208)

All patients Change in diagnosis

Primary prevention (n = 115)

Primary prevention Change in diagnosis

Secondary prevention (n = 93)

Secondary prevention Change in diagnosis

Acute MI

2

2 (1)

1

1 (1)

1

1 (1)

Cardiac storage disease

1

0 (0)

1

0 (0)

0

0 (0)

ARVC

5

3 (1)

1

0 (0)

4

3 (3)

Idiopathic DCM

43

13 (6)

33

9 (8)

10

4 (4)

HCM

7

2 (1)

3

1 (1)

4

1 (1)

HHD

25

22 (11)

11

11 (10)

14

11 (12)

ICM

63

8 (4)

40

2 (2)

23

6 (6)

NCCM

1

1 (0.5)

0

0 (0)

1

1 (1)

Normal (prior LGE (+) VT ablation lesions)

4

4 (2)

1

1 (1)

3

3 (3)

Normal

21

10 (5)

5

4 (3)

16

6 (6)

Post–acute myocarditis

20

13 (6)

9

5 (4)

11

8 (9)

PPCM

2

0 (0)

2

0 (0)

0

0 (0)

Cardiac sarcoidosis

7

4 (2)

4

2 (2)

3

2 (2)

Systemic sclerosis

1

0 (0)

0

0 (0)

1

0 (0)

TOF

1

0 (0)

0

0 (0)

1

0 (0)

VHD

5

1 (0.5)

4

1 (1)

1

0 (0)

Total

208

83 (40)

115

37 (32)

93

46 (49)*

  1. Values are n (%) for all, primary and secondary prevention groups. MI myocardial infarction; ARVC arrhythmogenic right-ventricular cardiomyopathy; DCM dilative cardiomyopathy; HCM hypertrophic cardiomyopathy; HHD hypertensive heart disease; ICM ischemic cardiomyopathy; NCCM non-compaction cardiomyopathy; LGE late gadolinium enhancement; VT ventricular tachycardia; PPCM peripartum cardiomyopathy; TOF tetralogy of Fallot; VHD valvular heart disease. * p = 0.011 for the comparison of primary versus secondary prevention